03.05.25 -- How Do We Categorize CDMOs?

This white paper from Upperton Pharma Solutions explores the use of spray drying in pharmaceuticals, its role in enhancing the bioavailability of poorly soluble APIs, and its application in creating dry powder pulmonary and nasal dosage forms. Click to learn more.

The two most common hot water for injection (WFI) generation methods are multi-effect distillation (MED) and vapor compression (VC). Here, the author reviews significant differences between each method in terms of operational principles and energy efficiency.

Consider these important factors when weighing your contract service provider options. These “Three Cs” can indicate whether a service provider has the capabilities desired by a drug sponsor.

Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.

Learn how a partner company that is committed to assisting manufacturers with calibration and optimal set-point establishment can serve as a valuable resource in achieving optimal tablet production.

Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.

The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.

Review an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties such as low aqueous solubility and poor bioavailability.

Enzalutamide and apalutamide, used for advanced prostate cancer, are not druggable in their crystalline form due to low solubility, so they are marketed as amorphous solid dispersions. Join on March 12th to learn how Nanoforming these drugs into high-load nanocrystals can reduce pill size, enhance performance, and extend market exclusivity while benefiting patients.

Discover how SK pharmteco's innovative La Porte, Texas facility combines advanced technology, sustainability, and strategic efficiency to redefine excellence in pharmaceutical manufacturing.

Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS) technology for the manufacture of API nanoparticles to GMP standards.

Jonas Nilsson, Principal Scientist based in Karlskoga, Sweden, leads a team of synthetic chemists focused on process development and optimization.

Lonza's Route Scouting Service empowers biotech partners to overcome the complexities of API development and bring life-changing medicines to market faster.